Rethinking Terminology: Insights from 2030 IN SIGHT LIVE

During the IAPB 2030 In Sight Live event in Mexico City this past June, a pivotal debate centred around an important question for the eye health community: Should diabetic retinopathy be relabelled as diabetic eye disease? This discussion has profound implications for how we research, address, and communicate diabetes-related vision issues. As World Diabetes Day approaches, the debate is timely, underscoring the need for adequate terminology that resonates with healthcare providers, patients, and the broader sector. 

Advocates for retaining the term diabetic retinopathy emphasised that this label keeps the focus on the retina, the part of the eye most affected by diabetes. They argued that specificity in terminology supports targeted interventions and clear communication, which are crucial for research, treatment, and public health efforts focused on retinal complications. 

On the other hand, proponents of adopting diabetic eye disease presented a case for a more comprehensive term that better captures the full range of diabetes-related eye conditions. They pointed out that diabetes can also lead to conditions such as cataracts and glaucoma. A broader label, they argued, would promote a more holistic understanding and approach to eye care, benefiting both patient awareness and clinical practice. 

The debate sparked lively discussions among attendees, reflecting the diversity of perspectives within the eye health community. These discussions are currently being carefully documented, and the insights will soon be shared with a wider audience. By disseminating these reflections, IAPB hopes to contribute to an informed and evolving dialogue that may influence future care strategies, educational initiatives, and public health messaging. 

As these insights reach a global audience, we look forward to seeing how they will shape our collective efforts toward improving eye health outcomes for people with diabetes.